References
- Nebel O T, Fornes M F, Castell D O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis Sci 1976; 21: 953–6
- Howard P J, Heading R C. Epidemiology of gastroesophageal reflux disease. World J Surg 1992; 16: 288–93
- Berstad A, Weberg R, Frøyshov Larsen I, Hoel B, Hauer‐Jensen M. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986; 21: 55–8
- Howard P J, Maher L, Pryde A, Heading R C. Symptomatic gastro‐oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro‐oesophageal reflux disease. Gut 1991; 32: 128–32
- Ben Rejeb M, Bouché O, Zeitoun P. Study of 47 consecutive patients with peptic esophageal stricture compared with 3880 cases of reflux esophagitis. Dig Dis Sci 1992; 37: 733–6
- Wienbeck M, Li Q. Cisapride in gastro‐oesophageal reflux disease: effects on oesophageal motility and intra‐oesophageal pH. Scand J Gastroenterol 1989; 165(24 Suppl)13–8
- Baldi F, Ferrarini F, Longanesi A, Angeloni M, Ragazzini M, Barbara L. Effect of short‐term cisapride treatment on gastro‐oesophageal reflux disease. Prog Med 1987; 1(43 Suppl)29–34
- Collins B J, Spence R A J, Ferguson R, Laird J, Love A H G. Cisapride: influence on oesophageal and gastric emptying and gastro‐oesophageal reflux in patients with reflux oesophagitis. Hepatogastroenterol 1987; 34: 113–6
- Lepoutre L, Vanderlinden I, Bollen G, Vandewalle N, Cabooter M, Laukens P. Controlled study of cisapride in the treatment of grade II and III oesophagitis. Gastroenterology 1987; 92: 1501A
- Baldi F, Bianchi Porro G, Dobrilla G, Iascone C, Lobello R, Marzio L, et al. Cisapride versus placebo in reflux esophagitis. J Clin Gastroenterol 1988; 10: 614–8
- Dodds W, Champion M, Orr W, Robinson M, Spechler S, Gilmore P, et al. Oral cisapride in GERD: a double‐blind placebo‐controlled multicenter trial. Gastroenterology 1989; 96: A126
- Toussaint J, Gossuin A, Deruyttere M, Hublé F, Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut 1991; 32: 1280–5
- DeMicco M, Berenson M, Wu W, Castell D, Lanza F, Robinson M, et al. Cisapride in the treatment of GERD: a double‐blind, placebo‐controlled multicenter dose‐response trial. Gastroenterology 1992; 102: A59
- Faruqui S, Sigmund C, Smith R, Fitch D, Mellow M, Orr W, et al. Cisapride in the treatment of GERD: a double‐blind, placebo‐controlled multicenter dose‐response trial. Gastroenterology 1992; 102: A66
- Blum A L, Adami B, Bouzo M H, Brandstatter G, Fumagalli I, Galmiche J P, et al. Effect of cisapride on relapse of esophagitis. A multinational, placebo‐controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993; 38: 551–60
- Tytgat G N J, Anker Hansen O J, Carling L, de Groot G H, Geldof H, Glise H, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992; 27: 175–83
- de Boer W A, Tytgat G N J. Review article: drug therapy for reflux oesophagitis. Aliment Pharmacol Ther 1994; 8: 147–57
- Savary M, Miller G. Ľoesophage. Manuel et atlas ďendoscopie. Verlag Gassmann AG, Soleure, Suisse 1977
- Report of a working party. World Congress of Gastroenterology, Rome, 1988
- Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106–10
- Tytgat G N J, Blum A L, Verlinden M. Prognostic factors for relapse and maintenance treatment with cisapride in gastro‐oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9: 271–80
- Waldum H L, Amestad J S, Brenna E, Eide I, Syversen U, Sandvik A K. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gastroenterology 1996; 110: A289
- Prewett E J, Hudson M, Nwokolo C U, Sawyerr A M, Pounder R E. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology 1991; 100: 873–7
- Kimmig J M. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies. Aliment Pharmacol Ther 1995; 9: 281–6